Evidence map›Paper›PMID 29072833›Full record

ReviewBiochemistry2018

Radical Breakthroughs in Natural Product and Cofactor Biosynthesis.

Kenichi Yokoyama

Open access · greenAbstract readReview
In one paragraph

Review in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kenichi YokoyamaDepartment of Biochemistry, Duke University Medical Center , Durham, North Carolina 27710, United States.ORCID 0000-0001-5625-469X
Duke Medical Center · US

Funding

Biosynthesis of peptidyl nucleoside antifungal antibioticsR01GM115729 · NIGMS · DUKE UNIVERSITY · PI YOKOYAMA, KENICHI · 2015 to 2023
$3.1M
Mechanism of cofactor biosynthesis required for chronic bacterial infectionR01GM112838 · NIGMS · DUKE UNIVERSITY · PI YOKOYAMA, KENICHI · 2015 to 2023
$2.8M
NIGMS NIH HHS R01 GM112838NIGMS NIH HHS R01 GM115729
6 · The paper itself

Abstract

The radical SAM (S-adenosyl-l-methionine) superfamily is one of the largest group of enzymes with >113000 annotated sequences [Landgraf, B. J., et al. (2016) Annu. Rev. Biochem. 85, 485-514]. Members of this superfamily catalyze the reductive cleavage of SAM using an oxygen sensitive 4Fe-4S cluster to transiently generate 5'-deoxyadenosyl radical that is subsequently used to initiate diverse free radical-mediated reactions. Because of the unique reactivity of free radicals, radical SAM enzymes frequently catalyze chemically challenging reactions critical for the biosynthesis of unique structures of cofactors and natural products. In this Perspective, I will discuss the impact of characterizing novel functions in radical SAM enzymes on our understanding of biosynthetic pathways and use two recent examples from my own group with a particular emphasis on two radical SAM enzymes that are responsible for carbon skeleton formation during the biosynthesis of a cofactor and natural products.

Indexed as

Biological ProductsCarbon-Carbon LyasesCoenzymesCrystallography, X-RayEscherichia coli ProteinsGuanosine TriphosphateHumansIsomerasesMetalloproteinsModels, MolecularMolecular StructureMolybdenum CofactorsNuclear ProteinsOrganophosphorus CompoundsProtein ConformationPteridinesBiological ProductsCarbon-Carbon LyasesCoenzymesEscherichia coli ProteinsGuanosine TriphosphateIsomerasesMetalloproteinsMoaA protein, E coliMoaC protein, E coliMOCS1 protein, humanMolybdenum CofactorsmolybdopterinNuclear ProteinsnulibryOrganophosphorus CompoundsPteridinesPterinsRecombinant ProteinsS-Adenosylmethionine

Identifiers

PMID29072833
PMCPMC5790616
OpenAlexW2765819225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.